000 | 02000 a2200565 4500 | ||
---|---|---|---|
005 | 20250517115734.0 | ||
264 | 0 | _c20181211 | |
008 | 201812s 0 0 eng d | ||
022 | _a1473-1150 | ||
024 | 7 |
_a10.1038/tpj.2016.67 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChang, S-W | |
245 | 0 | 0 |
_aGenome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes. _h[electronic resource] |
260 |
_bThe pharmacogenomics journal _c01 2018 |
||
300 |
_a106-112 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 | _aBlack or African American |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGenome-Wide Association Study _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMeta-Analysis as Topic |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aPharmacogenetics _xmethods |
650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
650 | 0 | 4 |
_aQuantitative Trait Loci _xgenetics |
700 | 1 | _aMcDonough, C W | |
700 | 1 | _aGong, Y | |
700 | 1 | _aJohnson, T A | |
700 | 1 | _aTsunoda, T | |
700 | 1 | _aGamazon, E R | |
700 | 1 | _aPerera, M A | |
700 | 1 | _aTakahashi, A | |
700 | 1 | _aTanaka, T | |
700 | 1 | _aKubo, M | |
700 | 1 | _aPepine, C J | |
700 | 1 | _aJohnson, J A | |
700 | 1 | _aCooper-DeHoff, R M | |
773 | 0 |
_tThe pharmacogenomics journal _gvol. 18 _gno. 1 _gp. 106-112 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/tpj.2016.67 _zAvailable from publisher's website |
999 |
_c26456789 _d26456789 |